ERn Financial LLC Sells 62 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

ERn Financial LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,700 shares of the healthcare conglomerate’s stock after selling 62 shares during the quarter. ERn Financial LLC’s holdings in UnitedHealth Group were worth $1,579,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Delta Financial Group Inc. raised its stake in UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after purchasing an additional 17 shares in the last quarter. Signature Resources Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after acquiring an additional 18 shares during the last quarter. Saxony Capital Management LLC increased its stake in UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock worth $270,000 after acquiring an additional 18 shares during the last quarter. GoalVest Advisory LLC lifted its stake in shares of UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 18 shares during the last quarter. Finally, Fiduciary Group LLC raised its holdings in UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after buying an additional 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

UNH has been the topic of a number of analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, October 1st. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, September 25th. Royal Bank of Canada raised their price target on UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Morgan Stanley increased their target price on UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Finally, Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $617.37.

Insider Buying and Selling

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Trading Down 8.4 %

UNH opened at $554.45 on Wednesday. The stock has a fifty day moving average price of $584.11 and a 200-day moving average price of $532.57. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market cap of $510.31 billion, a price-to-earnings ratio of 33.89, a PEG ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the previous year, the firm earned $6.14 EPS. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.